- Home
- NGL vs SVRA Comparison
NGL vs SVRA Comparison
Compare NGL & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGL
- SVRA
- Stock Information
- Founded
- NGL 1940
- SVRA N/A
- Country
- NGL United States
- SVRA United States
- Employees
- NGL N/A
- SVRA N/A
- Industry
- NGL Natural Gas Distribution
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NGL Utilities
- SVRA Health Care
- Exchange
- NGL Nasdaq
- SVRA Nasdaq
- Market Cap
- NGL 564.5M
- SVRA 552.6M
- IPO Year
- NGL 2011
- SVRA N/A
- Fundamental
- Price
- NGL $4.45
- SVRA $3.36
- Analyst Decision
- NGL
- SVRA Buy
- Analyst Count
- NGL 0
- SVRA 6
- Target Price
- NGL N/A
- SVRA $10.83
- AVG Volume (30 Days)
- NGL 289.1K
- SVRA 2.0M
- Earning Date
- NGL 11-12-2024
- SVRA 11-12-2024
- Dividend Yield
- NGL N/A
- SVRA N/A
- EPS Growth
- NGL N/A
- SVRA N/A
- EPS
- NGL N/A
- SVRA N/A
- Revenue
- NGL $6,239,231,000.00
- SVRA N/A
- Revenue This Year
- NGL N/A
- SVRA N/A
- Revenue Next Year
- NGL $3.50
- SVRA N/A
- P/E Ratio
- NGL N/A
- SVRA N/A
- Revenue Growth
- NGL N/A
- SVRA N/A
- 52 Week Low
- NGL $3.84
- SVRA $2.82
- 52 Week High
- NGL $6.20
- SVRA $5.70
- Technical
- Relative Strength Index (RSI)
- NGL 56.50
- SVRA 45.73
- Support Level
- NGL $3.84
- SVRA $2.82
- Resistance Level
- NGL $4.55
- SVRA $4.30
- Average True Range (ATR)
- NGL 0.21
- SVRA 0.30
- MACD
- NGL 0.04
- SVRA -0.03
- Stochastic Oscillator
- NGL 85.87
- SVRA 36.82
About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, and for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.